Chandan Healthcare Limited acquires Ansh Diagnostics & Health Care units in Ghaziabad
Chandan Healthcare Ltd · Healthcare Services
What the filing says
- Acquisition date: 25-09-2026; units located at Plot No. 17, Gyan Khand 2, and A-323 (Raj Hansh Tower), Ghaziabad, Uttar Pradesh
- The acquisition is not a related party transaction; no interest of promoter/promoter group in the acquired units
- No governmental or regulatory approvals required; acquisition aligns with company’s strategy to expand healthcare diagnostics network
Why it's rated notable: The company has completed the acquisition of two Ansh Diagnostics units in Ghaziabad with no consideration amount stated, so the size is judged as a small acquisition of diagnostic units rather than a high-level business change.
Original filing
General Updates
Read the filing on NSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other acquisition / merger filings this fortnight
- Acquisition / mergerSwelect EnergySwelect Energy Systems to acquire 100% shares of Sushma Solar Energy Pvt Ltd
- Acquisition / mergerUgro Capital LtdUGRO Capital Ltd announces NCLT hearing date for amalgamation scheme with Profectus
- Acquisition / mergerCyient LtdCyient Limited announces Q2 and H1 FY27 financial results and corporate updates
- Acquisition / mergerSagilitySagility Limited reports Q2 FY27 financial results and declares interim dividend
- Acquisition / mergerShyam Metalics & Energy LtdShyam Sel and Power Ltd seeks NCLT approval for scheme to amalgamate Shree Venkateshwara Electrocast Pvt Ltd
- Acquisition / mergerPetronet LNG LtdPetronet LNG signs binding term sheet with Gruner Renewable for CBG JV
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.